Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson’s Disease: A Case Report

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00608
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Three Consecutive Monthly Intravitreal Ranibizumab for Choroidal Neovascularization in Central Serous Choriorethinopathy: A Case Report

Open Journal of Ophthalmology
2012English

Long-Term Perseveration in Alzheimer’s Disease: A Case Report

Behavioural Neurology
MedicineNeurologyPhysiological PsychologyNeuropsychology
1991English

Central Pain in Parkinson’s Disease: A Case Report

Case Reports in Clinical Medicine
2018English

Midnolin Is a Confirmed Genetic Risk Factor for Parkinson’s Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2019English

Intravitreal Triamcinolone Acetonide in Eales' Disease: A Case Report

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2004English

Dementia in Long-Term Parkinson’s Disease Patients: A Multicentre Retrospective Study

npj Parkinson's Disease
2020English

Periodontitis: A Potential Risk Factor for Alzheimer's Disease

BDJ Team
2016English

Ageing as a Risk Factor for Disease

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2012English

Snoring as a Risk Factor for Disease

BMJ
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy